Th22 cells control colon tumorigenesis through STAT3 and Polycomb Repression complex 2 signaling

References

• Deng J, Liu Y, Lee H, Herrmann A, Zhang W, Zhang C, Shen S, Priceman SJ, Kujawski M, Pal SK et al. S1PR1-STAT3 signaling is crucial for myeloid cell colonization at future metastatic sites. Cancer Cell 2012; 21:642-54; PMID:22624714; http://dx.doi.org/10.1016/j.ccr.2012.03.039
   PubMed Web of Science ®Google Scholar
• Spits H, Di Santo JP. The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. Nat Immunol 2011; 12:21-7; PMID:21113163; http://dx.doi.org/10.1038/ni.1962
   PubMed Web of Science ®Google Scholar
• Basu R, O'Quinn DB, Silberger DJ, Schoeb TR, Fouser L, Ouyang WJ, Hatton RD, Weaver CT. Th22 Cells Are an Important Source of IL-22 for Host Protection against Enteropathogenic Bacteria. Immunity 2012; 37:1061-75; PMID:23200827; http://dx.doi.org/10.1016/j.immuni.2012.08.024
   PubMed Web of Science ®Google Scholar
• Song K, Nam YJ, Luo X, Qi X, Tan W, Huang GN, Acharya A, Smith CL, Tallquist MD, Neilson EG et al. Heart repair by reprogramming non-myocytes with cardiac transcription factors. Nature 2012; 485:599-604; PMID:22660318; http://dx.doi.org/10.1038/nature11139
   PubMed Web of Science ®Google Scholar
• Kryczek I, Lin Y, Nagarsheth N, Peng D, Zhao L, Zhao E, Vatan L, Szeliga W, Dou Y, Owens S et al. IL-22(+)CD4(+) T cells promote colorectal cancer stemness via STAT3 transcription factor activation and induction of the methyltransferase DOT1L. Immunity 2014; 40:772-84; PMID:24816405; http://dx.doi.org/10.1016/j.immuni.2014.03.010
   PubMed Web of Science ®Google Scholar
• Yu LZ, Wang HY, Yang SP, Yuan ZP, Xu FY, Sun C, Shi RH. Expression of interleukin-22/STAT3 signaling pathway in ulcerative colitis and related carcinogenesis. World J Gastroenterol 2013; 19:2638-49; PMID:23674871; http://dx.doi.org/10.3748/wjg.v19.i17.2638
   PubMed Web of Science ®Google Scholar
• Jiang R, Wang H, Deng L, Hou J, Shi R, Yao M, Gao Y, Yao A, Wang X, Yu L et al. IL-22 is related to development of human colon cancer by activation of STAT3. BMC Cancer 2013; 13:59; PMID:23379788; http://dx.doi.org/10.1186/1471-2407-13-59
   PubMed Web of Science ®Google Scholar
• Andoh A, Zhang Z, Inatomi O, Fujino S, Deguchi Y, Araki Y, Tsujikawa T, Kitoh K, Kim-Mitsuyama S, Takayanagi A et al. Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts. Gastroenterology 2005; 129:969-84; PMID:16143135; http://dx.doi.org/10.1053/j.gastro.2005.06.071
   PubMed Web of Science ®Google Scholar
• Wolk K, Kunz S, Witte E, Friedrich M, Asadullah K, Sabat R. IL-22 increases the innate immunity of tissues. Immunity 2004; 21:241-54; PMID:15308104; http://dx.doi.org/10.1016/j.immuni.2004.07.007
   PubMed Web of Science ®Google Scholar
• Aujla SJ, Chan YR, Zheng M, Fei M, Askew DJ, Pociask DA, Reinhart TA, McAllister F, Edeal J, Gaus K, Husain S et al. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat Med 2008; 14:275-81; PMID:18264110; http://dx.doi.org/10.1038/nm1710
   PubMed Web of Science ®Google Scholar
• Zheng Y, Valdez PA, Danilenko DM, Hu Y, Sa SM, Gong Q, Abbas AR, Modrusan Z, Ghilardi N, de Sauvage FJ et al. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med 2008; 14:282-9; PMID:18264109; http://dx.doi.org/10.1038/nm1720
   PubMed Web of Science ®Google Scholar
• Pickert G, Neufert C, Leppkes M, Zheng Y, Wittkopf N, Warntjen M, Lehr HA, Hirth S, Weigmann B, Wirtz S et al. STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing. J Exp Med 2009; 206:1465-72; PMID:19564350; http://dx.doi.org/10.1084/jem.20082683
   PubMed Web of Science ®Google Scholar
• Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, Wang Z, Wei G, Chepelev I, Zhao K. High-resolution profiling of histone methylations in the human genome. Cell 2007; 129:823-37; PMID:17512414; http://dx.doi.org/10.1016/j.cell.2007.05.009.
   PubMed Web of Science ®Google Scholar
• Varambally S, Dhanasekaran SM, Zhou M, Barrette TR, Kumar-Sinha C, Sanda MG, Ghosh D, Pienta KJ, Sewalt RG, Otte AP et al. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 2002; 419:624-9; PMID:12374981; http://dx.doi.org/10.1038/nature01075
   PubMed Web of Science ®Google Scholar
• Kleer CG, Cao Q, Varambally S, Shen R, Ota I, Tomlins SA, Ghosh D, Sewalt RG, Otte AP, Hayes DF et al. EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Proc Natl Acad Sci U S A 2003; 100:11606-11; PMID:14500907; http://dx.doi.org/10.1073/pnas.1933744100
   PubMed Web of Science ®Google Scholar
• Mimori K, Ogawa K, Okamoto M, Sudo T, Inoue H, Mori M. Clinical significance of enhancer of zeste homolog 2 expression in colorectal cancer cases. Eur J Surg Oncol 2005; 31:376-80; PMID:15837043; http://dx.doi.org/10.1016/j.ejso.2004.11.001
   PubMed Web of Science ®Google Scholar
• Cao R, Zhang Y. The functions of E(Z)/EZH2-mediated methylation of lysine 27 in histone H3. Curr Opin Genet Dev 2004; 14:155-64; PMID:15196462; http://dx.doi.org/10.1016/j.gde.2004.02.001
   PubMed Web of Science ®Google Scholar
• Subramanian A, Kuehn H, Gould J, Tamayo P, Mesirov JP. GSEA-P: a desktop application for Gene Set Enrichment Analysis. Bioinformatics 2007; 23:3251-3; PMID:17644558; http://dx.doi.org/10.1093/bioinformatics/btm369
   PubMed Web of Science ®Google Scholar
• Yu W, Chory EJ, Wernimont AK, Tempel W, Scopton A, Federation A, Marineau JJ, Qi J, Barsyte-Lovejoy D, Yi J et al. Catalytic site remodelling of the DOT1L methyltransferase by selective inhibitors. Nat Commun 2012; 3:1288; PMID:23250418; http://dx.doi.org/10.1038/ncomms2304
   PubMed Web of Science ®Google Scholar
• Kamanaka M, Huber S, Zenewicz LA, Gagliani N, Rathinam C, O'Connor W, Jr., Wan YY, Nakae S, Iwakura Y, Hao L et al. Memory/effector (CD45RB(lo)) CD4 T cells are controlled directly by IL-10 and cause IL-22-dependent intestinal pathology. J Exp Med 2011; 208:1027-40; PMID:21518800; http://dx.doi.org/10.1084/jem.20102149
   PubMed Web of Science ®Google Scholar
• Huber S, Gagliani N, Zenewicz LA, Huber FJ, Bosurgi L, Hu B, Hedl M, Zhang W, O'Connor W, Jr., Murphy AJ et al. IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine. Nature 2012; 491:259-63; PMID:23075849; http://dx.doi.org/10.1038/nature11535
   PubMed Web of Science ®Google Scholar
• Jiang R, Tan Z, Deng L, Chen Y, Xia Y, Gao Y, Wang X, Sun B. Interleukin-22 promotes human hepatocellular carcinoma by activation of STAT3. Hepatology 2011; 54:900-9; PMID:21674558; http://dx.doi.org/10.1002/hep.24486
   PubMed Web of Science ®Google Scholar
• Zhang W, Chen Y, Wei H, Zheng C, Sun R, Zhang J, Tian Z. Antiapoptotic activity of autocrine interleukin-22 and therapeutic effects of interleukin-22-small interfering RNA on human lung cancer xenografts. Clin Cancer Res 2008; 14:6432-9; PMID:18927282; http://dx.doi.org/10.1158/1078-0432.CCR-07-4401
   PubMed Web of Science ®Google Scholar
• Kim K, Kim G, Kim JY, Yun HJ, Lim SC, Choi HS. Interleukin-22 promotes epithelial cell transformation and breast tumorigenesis via MAP3K8 activation. Carcinogenesis 2014; 35:1352-61; PMID:24517997; http://dx.doi.org/10.1093/carcin/bgu044
   PubMed Web of Science ®Google Scholar
• Huang YH, Cao YF, Jiang ZY, Zhang S, Gao F. Th22 cell accumulation is associated with colorectal cancer development. World J Gastroenterol 2015; 21:4216-24; PMID:25892871; http://dx.doi.org/10.3748/wjg.v21.i14.4216
   PubMed Web of Science ®Google Scholar
• Kim CJ, Nazli A, Rojas OL, Chege D, Alidina Z, Huibner S, Mujib S, Benko E, Kovacs C, Shin LY et al. A role for mucosal IL-22 production and Th22 cells in HIV-associated mucosal immunopathogenesis. Mucosal Immunol 2012; 5:670-80; PMID:22854709; http://dx.doi.org/10.1038/mi.2012.72
   PubMed Web of Science ®Google Scholar
• Nishikawa S, Dewi DL, Ishii H, Konno M, Haraguchi N, Kano Y, Fukusumi T, Ohta K, Noguchi Y, Ozaki M et al. Transcriptomic study of dormant gastrointestinal cancer stem cells. Int J Oncol 2012; 41:979-84; PMID:22735680.
   PubMed Web of Science ®Google Scholar
• Lin YW, Ren LL, Xiong H, Du W, Yu YN, Sun TT, Weng YR, Wang ZH, Wang JL, Wang YC et al. Role of STAT3 and vitamin D receptor in EZH2-mediated invasion of human colorectal cancer. J Pathol 2013; 230:277-90; PMID:23424038; http://dx.doi.org/10.1002/path.4179
   PubMed Web of Science ®Google Scholar
• Cui TX, Kryczek I, Zhao L, Zhao E, Kuick R, Roh MH, Vatan L, Szeliga W, Mao Y, Thomas DG et al. Myeloid-derived suppressor cells enhance stemness of cancer cells by inducing microRNA101 and suppressing the corepressor CtBP2. Immunity 2013; 39:611-21; PMID:24012420; http://dx.doi.org/10.1016/j.immuni.2013.08.025
   PubMed Web of Science ®Google Scholar